课题基金 / 基金详情

GENETIC INFLUENCES ON MOVEMENT DISORDERS

GENETIC INFLUENCES ON MOVEMENT DISORDERS
遗传对运动障碍的影响
批准号:
8166922
负责人:
STEVEN Michael CRAMER
金额:
$0.03万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-12-01 至 2010-06-30

项目摘要

项目成果

STEVEN Michael CRAMER的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 该研究检查了肌张力障碍和假设,即与没有这种症状的健康受试者相比,表现出肌张力障碍症状的人具有过度活跃的皮质可塑性,因此BDNF val 66 met基因型变异的发生率相对较低。 本研究的具体目的是比较BDNF val 66 met基因型在诊断为肌张力障碍的人群中的频率与健康非肌张力障碍对照人群中的频率。 作为次要目的,还将检测两个受试者组是否存在DYT 1基因突变。 亚假设是,在具有DYT 1基因突变的罕见肌张力障碍受试者中,与携带该突变的肌张力障碍患者相比,在一个或两个等位基因中缺乏val 66 met突变将与更早的发病年龄和更严重的肌张力障碍症状水平相关。 请注意,一个对照组将是年龄匹配的健康受试者。 第二个对照组将是患有帕金森病的受试者,帕金森病也是一种基底神经节疾病,但与肌张力障碍不同,由于神经再生,并且假定其病理生理学与特发性肌张力障碍不同。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The study examines dystonia and the hypothesis that persons who demonstrate dystonic symptoms, as compared to healthy subjects who do not have such symptoms, have overactive cortical plasticity, and thus a relatively lower incidence of the BDNF val66met genotype variant. The specific aim of the current study is to compare the frequency of the BDNF val66met genotype in persons diagnosed with dystonia to the frequency in healthy, non-dystonic controls. As a secondary aim, both subject groups will also be tested for the presence of the mutation in the DYT1 gene. The subhypothesis is that among the rare dystonic subjects who have the DYT1 gene mutation the absence of the val66met mutation in one or both alleles will be associated with an earlier age of onset and more severe level of dystonic symptoms, as compared to dystonic patients who carry this mutation. Note that one control group will be age-matched, healthy subjects. A second control group will be subjects with Parkinson's disease, also a basal ganglia disorder, but, unlike dystonia, due to neurodgeneration and with a pathophysiology presumed different than idiopathic dystonia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ALZHEIMER'S DISEASE NEUROIMAGING PROTOCOL (ADNI)
EFFECTS OF DOPAMINE AND DOPAMINE RECEPTOR POLYMORPHISMS ON EXPERIENCE-DEPENDENT
GENETIC AND EXPERIENTIAL FACTORS INFLUENCING FUNCTIONAL ORGANIZATION OF MOTOR
CLINICAL TRIAL: SAFETY OF REPETITIVE TMS IN CHRONIC SUBCORTICAL STROKE
海外基金